Biosensors Perked Up By Japan, China News, Profitability Successes
Executive Summary
CV and critical care company Biosensors is on the brink of a global top 100 medtech company sales ranking: in the first nine months of FY15, it made total sales of US$232.5 million, which would make a year-end total of over $300 million a prospect. Its longer-term strategy is to strengthen its position in the cardiovascular market, expand its geographical reach and add new product lines and investment opportunities to grow into a multi-platformed international player.